# A Study of LY4178256 in Healthy Participants

> **NCT07698210** · PHASE1 · RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 88 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** LY4178256
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07698210
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-16
- **Primary completion:** 2028-03
- **Final completion:** 2028-03
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2026-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07698210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07698210, "A Study of LY4178256 in Healthy Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07698210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*